Gilead Sciences -announced- that a generic version of Truvada, an HIV prevention drug, will be available one year earlier than expected. It is hoped that the generic option will make the drug more affordable. The early release is the result of intense negotiations between Gilead and Teva Pharmaceuticals, the would-be maker of the generic drug. Currently, people in the U.S. are paying an astronomical...